News | Wearable Sensors | October 13, 2016

Biotricity Expands Partnership with the University of Calgary on Wearable Monitors

Partnership will continue to develop the next generation of medically relevant wearable monitors; Biotricity expects FDA response to 510(k) submission shortly

October 13, 2016 — Biotricity Inc. announced recently that it will be expanding its existing research partnership with the University of Calgary. In order to develop and validate the next generation of medically relevant wearable monitors, the focus of the new partnership will be on areas beyond cardiac medicine, including fetal monitoring and sleep apnea.

Biotricity’s goal is to develop a series of clinically accurate devices that are applicable in both clinical and home-based settings. The initial focus of this expanded partnership will be to investigate using heart rate variability monitoring (HRVM) to optimize recovery after surgery and medical illness, and to develop solutions for the fetal monitoring and sleep apnea markets as well.

David Liepert, Ph.D., a clinical assistant professor at the University of Calgary Cumming School of Medicine, anesthesiologist at AHS’ Rockyview General Hospital and lead investigator of the study added, “The Department of Anesthesia and Peri-Operative Medicine looks forward to expanding on the developmental heart rate variability monitoring  work we have already completed with the Bioflux device, and working with Biotricity's consumer-based Biolife device as well.”

He explained, “HRVM’s ability to simultaneously monitor internal physiology and activities of daily living combined with Biotricity’s convenience and portability seems ideal for tracking return-to-function and allowing early and individualized intervention and optimization. Maternal/fetal monitoring has long-included HRVM, and exploring the impact of offering convenience and portability to that patient group as well as the sleep apnea population is an exciting opportunity. We look forward to capitalizing on [Biotricity CEO and founder] Waqaas Al-Siddiq's expertise in wearable biometric monitoring, connectivity and data processing and are also exploring the benefits of creating a relationship with the University of Calgary's Schulich School of Engineering which would be of utmost value to Alberta's budding Biomedical Engineers."

In other news, Biotricity is expecting a response from the U.S. Food and Drug Administration (FDA) to their 510(k) submission within the next few weeks.

For more information:

Related Content

Male Triathletes May Be Putting Their Heart Health at Risk
News | Cardiac Diagnostics | January 09, 2018
Competitive male triathletes face a higher risk of a potentially harmful heart condition called myocardial fibrosis,...
ERT Acquires iCardiac Technologies
News | Cardiac Diagnostics | December 19, 2017
ERT recently announced it has acquired iCardiac Technologies, a provider of centralized cardiac safety and respiratory...
New Study Suggests Protein Could Protect Against Coronary Artery Disease

Patients with no obstructed blood flow in the coronary arteries had higher levels of CXCL5 (blue) compared to patients with moderate levels (green) or lower levels (yellow) of CXCL5, who had increased severity of coronary obstructions (indicated by the arrows). Credit: Schisler lab

News | Cardiac Diagnostics | December 07, 2017
December 7, 2017 — The buildup of plaque in the heart’s arteries is an unfortunate part of aging.
E-cigarettes Most Likely to be Used by Alcohol Drinkers and Former Cigarette Smokers, at American Heart Association (AHA), #AHA2017.
News | Cardiac Diagnostics | December 06, 2017
December 6, 2017 — Electronic cigarettes are more frequently used by people who recently quit smoking and alcohol dri
Lack of sleep may cause heart disease in older women. American heart Association, #AHA2017
News | Cardiac Diagnostics | December 06, 2017
December 6, 2017 — Older women who do not get enough sleep were more likely to have poor cardiovascular health, accor
New Tool Predicts Risk of Heart Attack in Older Surgery Patients
News | Cardiac Diagnostics | December 05, 2017
A tool designed to more accurately predict the risk of heart attack in older patients undergoing non-cardiac surgery...
EPIC Norfolk prospective population study showed any physical activity is better than none in older adults in preventing cardiovascular disease.

The EPIC Norfolk prospective population study showed any physical activity is better than none in older adults in preventing cardiovascular disease.

News | Cardiac Diagnostics | November 24, 2017
November 24, 2017 — Any physical activity in the elderly is better than none at all for reducing cardiovascular risk,
Analytics 4 Life Presents Clinical Data on Machine-Learned Cardiac Imaging Technology at TCT 2017
News | Cardiac Diagnostics | November 01, 2017
Analytics 4 Life announced it will be presenting new clinical data on the company's ongoing Coronary Artery Disease...
American Heart Association, Verily and AstraZeneca Launch One Brave Idea Science Innovation Center
News | Cardiac Diagnostics | October 20, 2017
The American Heart Association, Verily and AstraZeneca announced the opening of the One Brave Idea Science Innovation...
Overlay Init